关于靶向光生物调节仪联合应用的回顾性自身对照研究OA

Objective To observe the control effect of targeted photobiomodulator(TPBM)on myopia patients through a clinical retrospective self-comparison.Methods Clinical data of myopic patients treated with TPBM were col-lected,including axial length(AL),spherical equivalent refraction(SE),and choroidal thickness(ChT).Changes in these parameters before and after intervention were compared.Results A total of 79 patients were enrolled,comprising 53 pa-tients(106 eyes)in the TPBM+peripheral myopia defocus design spectacle lenses(PMDSL)group and 26 patients(52 eyes)TPBM+orthokeratology(OK)lens group.In the OK lens combined with TPBM group,the annual AL growth rate decreased by approximately 35.6％,and the mean monthly increase in ChT was approximately 70.8％.In the PMDSL combined with TPBM group,the annual AL rate decreased by approximately 67.6％,the annual progression of SE refrac-tion decreased by approximately 41.9％,and the mean monthly increase in ChT was approximately 54.7％.Conclusion The combined application of TPBM demonstrates a certain efficacy in delaying AL,refractive progression,and choroidal thinning in myopic patients.